UA80871C2 - 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension - Google Patents

5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension

Info

Publication number
UA80871C2
UA80871C2 UAA200510180A UAA200510180A UA80871C2 UA 80871 C2 UA80871 C2 UA 80871C2 UA A200510180 A UAA200510180 A UA A200510180A UA A200510180 A UAA200510180 A UA A200510180A UA 80871 C2 UA80871 C2 UA 80871C2
Authority
UA
Ukraine
Prior art keywords
diaminopyrazolo
hypertension
treatment
pyrimidines useful
pyrimidines
Prior art date
Application number
UAA200510180A
Inventor
Michael John Palmer
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority claimed from PCT/IB2004/001433 external-priority patent/WO2004096810A1/en
Publication of UA80871C2 publication Critical patent/UA80871C2/en

Links

Abstract

This invention relates to compounds of formula (I). , (I)
UAA200510180A 2003-04-29 2004-04-22 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension UA80871C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0309780 2003-04-29
PCT/IB2004/001433 WO2004096810A1 (en) 2003-04-29 2004-04-22 5,7-diaminopyrazolo`4,3-d!pyrimidines useful in the treatment of hypertension

Publications (1)

Publication Number Publication Date
UA80871C2 true UA80871C2 (en) 2007-11-12

Family

ID=36701543

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200510180A UA80871C2 (en) 2003-04-29 2004-04-22 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension

Country Status (5)

Country Link
CN (1) CN100439371C (en)
GT (1) GT200400083A (en)
TN (1) TNSN05276A1 (en)
UA (1) UA80871C2 (en)
ZA (1) ZA200506975B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3998260B1 (en) * 2013-03-15 2023-11-01 Cyclerion Therapeutics, Inc. Sgc stimulators
CN104672250B (en) * 2013-11-29 2017-11-07 广东东阳光药业有限公司 Substituted heteroaryl compound and combinations thereof and purposes
CN112608317A (en) * 2020-12-15 2021-04-06 植恩生物技术股份有限公司 Sildenafil citrate preparation method
CN115073354A (en) * 2021-03-11 2022-09-20 江苏润安制药有限公司 Preparation method of apremilast intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5091431A (en) * 1988-02-08 1992-02-25 Schering Corporation Phosphodiesterase inhibitors
DE10031584A1 (en) * 2000-06-29 2002-01-10 Merck Patent Gmbh 5-aminoalkyl-pyrazolo [4,3-d] pyrimidine
HUP0300725A3 (en) * 2000-08-11 2005-11-28 Pfizer Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
PE20030008A1 (en) * 2001-06-19 2003-01-22 Bristol Myers Squibb Co DUAL INHIBITORS OF PDE 7 AND PDE 4

Also Published As

Publication number Publication date
CN1780841A (en) 2006-05-31
CN100439371C (en) 2008-12-03
GT200400083A (en) 2005-03-03
TNSN05276A1 (en) 2007-07-10
ZA200506975B (en) 2006-12-27

Similar Documents

Publication Publication Date Title
RS20050810A (en) 5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
HK1068626A1 (en) Chemical compounds
MXPA03011197A (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents.
HK1118534A1 (en) Thieno-pyrimidine compounds having fungicidal activity
PL373645A1 (en) Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors
IL163781A0 (en) Purine derivatives as kinase inhibitors
TW200626559A (en) Anilino-pyrimidine analogs
TNSN05254A1 (en) Derivatives of 2-acylamino-4-phenylthiazole, preparation method thereof and application of same in therapeutics
WO2004074244A3 (en) Pyrimidine compounds
MXPA03006093A (en) N(phenylsulphonyl)glycine derivatives and their therapeutic use.
TW200510407A (en) Novel pyrrolodihydroisoquinolines as PDE 10 inhibitors
MXPA04003886A (en) Thiopene- amd thiazolesulfonamides as antineoplastic agents.
EP1675552A4 (en) Preperation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors
DK1742950T3 (en) The pyrazolo [4,3-d] pyrimidines
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
EP1667685A4 (en) Quinazoline potassium channel inhibitors
MXPA05013149A (en) Imidazole derivatives as glutmate receptor antagonists.
HK1077827A1 (en) Diazabicyclononane and-decane derivatives their use as opioid receptor ligands
WO2005009348A3 (en) Substituted purine derivatives
MXPA04001419A (en) Isoxazolopyridinones and use thereof in the treatment of parkinson's disease.
MXPA06000372A (en) Silicon compounds and their use.
MXPA04005988A (en) 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives.
UA80871C2 (en) 5,7-diaminopyrazolo[4,3-d]pyrimidines useful in the treatment of hypertension
TW200613271A (en) Crystalline forms of 1,24(s)-dihydroxy vitamin d2
AU2003266093A1 (en) Cyclooct-(en-)yl derivatives for use as fragrances